trending Market Intelligence /marketintelligence/en/news-insights/trending/FhmQttNv4BmtydX8oy5slw2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Report: Swiss medical device company Medacta plans IPO

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Report: Swiss medical device company Medacta plans IPO

Medacta Group SA, a family-owned Swiss company developing orthopedic implants, is planning an IPO on the SIX Swiss Exchange, Reuters reported.

The planned IPO would be a secondary offering and is expected to close in the second quarter of 2019. The Siccardi family, which founded the company, is expected to retain control after the offer.

An over-allotment option is also planned on existing shares, Reuters said.

Credit Suisse and Morgan Stanley are acting as joint global coordinators for the IPO, while JP Morgan and UBS Investment Bank are the joint bookrunners for the offer. Rothschild was also appointed as independent financial adviser to the Swiss company.